{"id":"W4224290890","doi":"10.1056/nejmoa2117344","title":"Ivosidenib and Azacitidine in <i>IDH1</i> -Mutated Acute Myeloid Leukemia","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":483,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Servier; Agios Pharmaceuticals","keywords":"Azacitidine; Medicine; Placebo; Myeloid leukemia; Internal medicine; Hazard ratio; Clinical endpoint; Population; Oncology; Randomized controlled trial; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006146465,0.0002340184,0.0006013254,0.0001256335,0.0001104256,0.0001952779,0.0001944118,0.0003627233,0.001359773],"category_scores_gemma":[0.001013704,0.0001133373,0.0002908666,0.0001496424,0.0002182031,0.0001491,0.0001536296,0.0005180274,0.0001419026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002881157,"about_ca_system_score_gemma":0.0003264274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002851241,"about_ca_topic_score_gemma":0.0006525278,"domain_scores_codex":[0.9997143,0.0001717004,0.00002036187,0.00003287515,0.0000254244,0.00003538268],"domain_scores_gemma":[0.9997072,0.0001098453,0.00008260512,0.00001227586,0.000008218593,0.00007987563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5255075,0.01057662,0.08131585,0.001460367,0.001392635,0.0007056179,0.0002691025,0.001821451,0.02736981,0.0005033119,0.001735167,0.3473427],"study_design_scores_gemma":[0.2093481,0.5363742,0.2196003,0.0004483961,0.002027251,0.002426817,0.0001664672,0.002820509,0.01212356,0.000770498,0.01385573,0.00003823515],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942034,0.004411899,0.0002068622,0.0001440475,0.00004451867,0.0001140425,0.00005885517,0.000009071261,0.0008072123],"genre_scores_gemma":[0.9979929,0.001062758,0.0003270982,0.0001142632,0.00006588954,0.00009829382,0.00009157606,0.000001488643,0.000245832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001359773,"threshold_uncertainty_score":0.004548848,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01712971759250661,"score_gpt":0.2887805397604379,"score_spread":0.2716508221679313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}